Search
for
Sort by
Research 241–270 of 1000+
- An update on diagnosis and treatment of female pattern hair loss
- Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide
- Updates on Hirsutism: A Narrative Review
- Acne
- Hair Loss in Women
- Evidence-based approach to cutaneous hyperandrogenism in women
- Treatment strategies for alopecia
- Contemporary medical therapy for polycystic ovary syndrome
- Polycystic ovarian syndrome
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- Transfollicular enhancement of gel containing cationic niosomes loaded with unsaturated fatty acids in rice (Oryza sativa) bran semi-purified fraction
- Common Dermatologic Conditions
- Hormonal Treatment for Skin Androgen-Related Disorders
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Current management strategies for cutaneous T-cell lymphoma
- Frontal fibrosing alopecia: efficacy of treatment modalities
- Understanding Polycystic Ovary Syndrome
- Acne Vulgaris
- Alopecia: managing the basics
- Differential impact of environmental factors on systemic and localized autoimmunity
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Prolactin and the Skin: A Dermatological Perspective on an Ancient Pleiotropic Peptide Hormone
- Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
- Approach to the adult female patient with diffuse nonscarring alopecia
- Bacteria induce skin regeneration via IL-1β signaling
- Hair: What is New in Diagnosis and Management?
- Topical ketoconazole: a systematic review of current dermatological applications and future developments
- Azelaic Acid: Mechanisms of Action and Clinical Applications
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure
- Promotion of anagen, increased hair density and reduction of hair fall in a clinical setting following identification of FGF5-inhibiting compounds via a novel 2-stage process